Derma Sciences (DSCI) Tops Q3 EPS by 8c

Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.35), $0.08 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $22.31 million.

For earnings history and earnings-related data on Derma Sciences (DSCI) click here.

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• L&T Financial Holdings (LTFH:IN) PT Raised to INR380 at Axis Capital Limited
• Financial Select Sector SPDR ETF (XLF) spreader of 20K contracts of July 31 weekly 57 and 59 calls into bank earnings season